Nicotine Skin Patches |
Habitrol; NicoDerm; Nicotine transdermal system; Nicotrol; ProStep |
Clinical Trial: PHARMACOTHERAPIES: EFFICACY, MECHANISMS, AND ALGORITHMS - 1
This study is not yet open for patient recruitment.
Purpose
. The proposed work will advance the understanding and effectiveness of tobacco dependence treatment and result in more smokers quitting successfully.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| nicotine | Drug: nicotine | Phase I |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Placebo Control
Official Title: PHARMACOTHERAPIES: EFFICACY, MECHANISMS, AND ALGORITHMS
Study start: September 2004; Expected completion: February 2010
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Smoke at least 10 cigarettes per day for the previous 6 months
- Expired CO > 9 ppm
- Motivated to quit smoking
- Able to read and write English
- Willing to complete required study assessments
Exclusion Criteria:
- Uncontrolled hypertension (systolic >180mm Hg or diastolic >110mm Hg)
- History of bipolar disorder or psychosis
- Myocardial infarction or other serious cardiac problem in the previous 4 weeks
- History of diagnosed anorexia and/or bulimia
- Diagnosis of Alcohol Dependence in the previous 6 months by participant self-report or drinking 6 or more drinks on six or more days a week
- History of seizure and/or serious head injury involving loss of consciousness
- Use of contraindicated medications (MAO inhibitors, bupropion, lithium, anticonvulsants, antipsychotics)
- Currently pregnant or breast-feeding
- Unwilling to use effective contraception during the treatment phase
- More than one participant from the same household
- Allergic reactions to 3 or more classes of drugs
Location and Contact Information
Wisconsin
UW-CTRI Madison Research site, Madison, Wisconsin, 53711 2027, United States
UW-CTRI Milwaukee Research site, Milwaukee, Wisconsin, 53233, United States
Timothy Baker, Ph.D., Principal Investigator, University of Wisconsin-Madison
More Information
Record last reviewed: April 2005
Last Updated: April 27, 2005
Record first received: April 27, 2005
ClinicalTrials.gov Identifier: NCT00109447
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-05-03
Source: ClinicalTrials.gov
Cache Date: May 4, 2005

Not Signed In -

